ReviewAdvanced pharmaceutical bulletin2023

Lutetium-177-Labeled Prostate-Specific Membrane Antigen-617 for Molecular Imaging and Targeted Radioligand Therapy of Prostate Cancer.

Rien Ritawidya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.